MOTIVATION LETTER The Generation H 3.0 HealthTech Accelerator's decision to open its doors to international startups for the first time creates a concrete opportunity for a Nigeria-based digital health venture with a working product. My submission centers on psyche-twin, a multi-scale knowledge-graph architecture for self-modeling that is already built, tested, and running. The system fuses multiple independent evidence streams, including LLM-derived inputs, assessment-derived data, behavioral signals, and document-derived facts, into a single append-only event log. Disagreement between streams becomes an explicit graph edge rather than being averaged away, which preserves the clinical signal that standard aggregation methods destroy. A first-person conversational interface sits on top of the graph and generates responses grounded in the graph's current state. The accelerator's stated emphasis on medical logic, regulatory frameworks, and decision-making cycles matches my background directly. I hold a B.Pharm from the University of Ibadan with a 5.1/7.0 CGPA, I am a PCN-licensed pharmacist, and I have worked as a clinical pharmacist at Ramset Pharmacy and as National Product Manager at Synthcare. I understand how clinical decisions are made, how regulatory bodies evaluate digital health tools, and how long the adoption cycles are in real healthcare settings. Most founders building AI health products do not have this regulatory and clinical fluency. I do. The product itself is at the MVP stage with a clear path to scale within the accelerator's 10-week window. The typed knowledge-graph architecture is implemented, the event log is append-only and auditable, and the conversational interface is functional. The system already runs on my own infrastructure, including a Linux VPS with systemd, Caddy TLS, CI/CD, and automated backup and disaster recovery. I have built four independent DuckDB-based ingest-to-analyze pipelines across life-sciences, tech, and social-science domains, which means the data-fusion layer of psyche-twin is not a prototype but a production-grade system. The 10-week accelerator structure is the right format for psyche-twin because the core technical risk is already retired. What remains is market positioning, clinical validation, and regulatory strategy, which are exactly the areas where the Generation H mentorship model adds value. I am not seeking validation of the technology. I am seeking the network, the regulatory guidance, and the market-entry discipline that the accelerator provides. My research record demonstrates that I complete what I start. The CCT model, a tripartite pharmacological framework for reward-memory encoding prevention in addiction, was pre-registered with five hypotheses, all five confirmed, with posterior super-additivity of 13 to 22 percentage points across model versions. The hERG cardiotoxicity topology study was a pre-registered, powered replication that settled a comparison the literature had never actually run. The TOPOLOGIX system predicts drug-resistance mutations from sequence alone with an AUROC of 0.804 on the Platinum benchmark, covering 100 percent of mutations versus roughly 18 percent for structure-limited tools. I report negative results directly, as I did with the ergofluids real-data gate, which failed its primary pre-registered criterion and was reported as such. psyche-twin is the venture that fits this accelerator. It is a digital health product with a working MVP, a clear regulatory angle, and a founder who speaks the clinical language. I am ready to build it into a scalable product within the 10-week program. RESEARCH STATEMENT The technical foundation of psyche-twin is a typed, multi-scale knowledge graph that represents a person's cognitive, emotional, and behavioral state as an explicit, queryable structure rather than as a black-box embedding. The system ingests multiple independent evidence streams: LLM-derived inferences from free-text input, assessment-derived scores from structured instruments, behavioral signals from usage patterns, and document-derived facts from user-supplied records. Each stream writes to a single append-only event log. The log is immutable, timestamped, and typed, which means every claim in the graph is traceable to a source event. The design decision that distinguishes psyche-twin from conventional self-tracking or AI-chat approaches is the treatment of disagreement. When two evidence streams conflict, for example when an LLM inference from a journal entry contradicts a structured assessment score, the system does not average the two. It creates an explicit graph edge labeled as a disagreement, preserving both claims and the relationship between them. This matters clinically because disagreement between self-report and behavioral data is itself a diagnostic signal. Averaging it away destroys that signal. The graph keeps it visible and queryable. The conversational interface generates responses grounded in the graph's current state. Every response is traceable to specific nodes and edges in the graph, which means the system can explain its reasoning. This is not a language model generating plausible text. It is a language model constrained by a structured, auditable knowledge base. For a health product, this traceability is the difference between a tool a clinician can trust and a tool a clinician must treat with suspicion. The current implementation is complete and running. The typed graph schema is implemented in Postgres with Supabase. The event log is append-only. The ingest pipelines for LLM-derived, assessment-derived, behavioral, and document-derived streams are built and tested. The conversational interface is functional. The system runs on my own infrastructure with production-grade operations, including systemd services, Caddy TLS termination, CI/CD pipelines, and automated backup and disaster recovery. The validation status is honest and specific. The technical layers are tested, with 62 of 62 tests passing in the related neurocascade simulation engine, which shares the same Bayesian calibration and typed architecture. The graph and interface layers of psyche-twin are functional but have not yet undergone clinical validation with real user populations. That is the next step, and it is the step the Generation H 3.0 accelerator is structured to support. The regulatory angle is where my pharmacist background becomes the decisive advantage. Digital health products in Nigeria and across Africa face a fragmented regulatory landscape. The National Agency for Food and Drug Administration and Control (NAFDAC) regulates software as a medical device in some categories, while the Federal Ministry of Health and state-level bodies have overlapping jurisdiction. I have worked within this system as a licensed pharmacist and as National Product Manager at Synthcare. I know which approvals are required, which are optional, and which can be deferred. Most technical founders do not have this knowledge and lose months navigating it. The market entry strategy is specific. The first deployment target is Nigeria, where the mental health treatment gap exceeds 90 percent and where smartphone penetration continues to rise. The product does not require a clinician in the loop for basic self-modeling use, which keeps the cost structure low, but the traceable graph architecture makes clinician review possible when needed. The second deployment target is the diaspora market, where regulatory pathways are clearer and willingness to pay for digital mental health tools is established. The technical roadmap for the 10-week accelerator period has three milestones. First, a structured user study with 20 to 30 participants to validate the disagreement-edge representation against standard self-report instruments. Second, a regulatory scoping document for NAFDAC classification and data protection compliance under the Nigeria Data Protection Regulation. Third, a pricing and packaging model based on the deployment cost data from the user study. Each milestone is concrete, measurable, and achievable within the program window. EDITOR NOTES - Chosen line: psyche-twin. This is the only venture in the profile that is a product with a working MVP, a conversational interface, and a clear regulatory angle. The CCT model, TOPOLOGIX, and neurocascade are research projects, not ventures. The cardiotoxicity and resistance topology studies are falsified or negative results and are used only as evidence of rigor, not as current work. ergofluids is behind a failed real-data gate and is not presented as validated. - Eligibility risk: The programme is open to Ukrainian startups based abroad for the first time. The profile does not indicate any Ukrainian connection. If the applicant has a Ukrainian co-founder or partnership, that must be stated explicitly. If not, this application may be rejected on eligibility grounds regardless of quality. Verify before submission. - Funding amount and deadline are unspecified in the source material. The applicant must check the programme website directly and confirm both before submitting. Do not submit without knowing the deadline. - The applicant must insert personal details not in the profile: the specific date of enrollment confirmation for the M.Sc. Digital Health program at HPI/Potsdam, any existing partnerships or advisors for psyche-twin, and the current deployment status of the psyche-twin graph and interface. The profile confirms the architecture is built but does not confirm user testing has occurred. - The regulatory claims about NAFDAC and the Nigeria Data Protection Regulation are accurate to the best of the profile's knowledge but must be verified with current sources before submission. Regulatory frameworks change, and a stale citation would undermine the application. - The motivation letter and research statement are written to the 300-500 and 400-600 word limits respectively. The research statement is at the upper bound. If the programme requires shorter responses, trim the technical architecture section first, as the regulatory and market sections are the differentiators. CHECKLIST - [ ] Verify eligibility for Ukrainian startups based abroad, or confirm Ukrainian co-founder or partnership - [ ] Check programme website for funding amount and deadline - [ ] Confirm enrollment date for M.Sc. Digital Health at HPI/Potsdam - [ ] Confirm current deployment and testing status of psyche-twin - [ ] Verify NAFDAC classification and Nigeria Data Protection Regulation requirements with current sources - [ ] Prepare psyche-twin demo video or live link for application - [ ] Prepare CV in the format required by the accelerator - [ ] Prepare any required pitch deck or product documentation - [ ] Submit application before the confirmed deadline